ArticleJAMA2014
Non-small cell lung cancer and precision medicine: a model for the incorporation of genomic features into clinical trial design.
Article in JAMA, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Meta-analysis of mRNA expression profiles to identify differentially expressed genes in lung adenocarcinoma tissue from smokers and non-smokers.Oncology reports · 2018Pooled it
- Investigating the role of oncogenic FAM83A as a prognostic biomarker in lung adenocarcinoma: Insights from smoker and non-smoker cohorts.Journal, genetic engineering & biotechnology · 2025Article
- Exploring potential genes and pathways related to lung cancer: a graph theoretical analysis.Bioinformation · 2023Article
- Preoperative computed tomography-based tumoral radiomic features prediction for overall survival in resectable non-small cell lung cancer.Frontiers in oncology · 2023Article
- ER predicts poor prognosis in male lung squamous cell cancer of stage IIIA-N2 disease after sequential adjuvant chemoradiotherapy.Frontiers in oncology · 2023Article
- Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer.Nature medicine · 2022Article
- Article
- PET/CT Radiomic Features: A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs.Frontiers in oncology · 2022Article
- Comparison of COVID-19 and Lung CancerFrontiers in oncology · 2021Review
- Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: a preferential benefit for squamous cell carcinoma.Radiology and oncology · 2020Article
- Development of an Oncogenic Driver Alteration Associated Immune-Related Prognostic Model for Stage I-II Lung Adenocarcinoma.Frontiers in oncology · 2020Article
- Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy.Molecular and cellular biochemistry · 2018Article
- A secondary RET mutation in the activation loop conferring resistance to vandetanib.Nature communications · 2018Article
- Precision oncology in the age of integrative genomics.Nature biotechnology · 2018Article
- Integrated analysis reveals key genes with prognostic value in lung adenocarcinoma.Cancer management and research · 2018Article
- Aberrant status and clinicopathologic characteristic associations of 11 target genes in 1,321 Chinese patients with lung adenocarcinoma.Journal of thoracic disease · 2018Article
- Mutational Landscapes of Smoking-Related Cancers in Caucasians and African Americans: Precision Oncology Perspectives at Wake Forest Baptist Comprehensive Cancer Center.Theranostics · 2017Article
- Gene aberrations for precision medicine against lung adenocarcinoma.Cancer science · 2016Review
- The VA Point-of-Care Precision Oncology Program: Balancing Access with Rapid Learning in Molecular Cancer Medicine.Biomarkers in cancer · 2016Article
- Extracellular vesicles: potential applications in cancer diagnosis, prognosis, and epidemiology.BMC clinical pathology · 2015Article
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
24846033What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.